Retinitis pigmentosa
Top Cited Papers
Open Access
- 11 October 2006
- journal article
- review article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 1 (1) , 40
Abstract
Retinitis pigmentosa (RP) is an inherited retinal dystrophy caused by the loss of photoreceptors and characterized by retinal pigment deposits visible on fundus examination. Prevalence of non syndromic RP is approximately 1/4,000. The most common form of RP is a rod-cone dystrophy, in which the first symptom is night blindness, followed by the progressive loss in the peripheral visual field in daylight, and eventually leading to blindness after several decades. Some extreme cases may have a rapid evolution over two decades or a slow progression that never leads to blindness. In some cases, the clinical presentation is a cone-rod dystrophy, in which the decrease in visual acuity predominates over the visual field loss. RP is usually non syndromic but there are also many syndromic forms, the most frequent being Usher syndrome. To date, 45 causative genes/loci have been identified in non syndromic RP (for the autosomal dominant, autosomal recessive, X-linked, and digenic forms). Clinical diagnosis is based on the presence of night blindness and peripheral visual field defects, lesions in the fundus, hypovolted electroretinogram traces, and progressive worsening of these signs. Molecular diagnosis can be made for some genes, but is not usually performed due to the tremendous genetic heterogeneity of the disease. Genetic counseling is always advised. Currently, there is no therapy that stops the evolution of the disease or restores the vision, so the visual prognosis is poor. The therapeutic approach is restricted to slowing down the degenerative process by sunlight protection and vitaminotherapy, treating the complications (cataract and macular edema), and helping patients to cope with the social and psychological impact of blindness. However, new therapeutic strategies are emerging from intensive research (gene therapy, neuroprotection, retinal prosthesis).Keywords
This publication has 57 references indexed in Scilit:
- Reductions in Serum Vitamin A Arrest Accumulation of Toxic Retinal Fluorophores: A Potential Therapy for Treatment of Lipofuscin-Based Retinal DiseasesInvestigative Ophthalmology & Visual Science, 2005
- Long-Term Restoration of Rod and Cone Vision by Single Dose rAAV-Mediated Gene Transfer to the Retina in a Canine Model of Childhood BlindnessMolecular Therapy, 2005
- The Association between Visual Acuity and Central Retinal Thickness in Retinitis PigmentosaInvestigative Ophthalmology & Visual Science, 2005
- Genotyping Microarray (Disease Chip) for Leber Congenital Amaurosis: Detection of Modifier AllelesInvestigative Ophthalmology & Visual Science, 2005
- Disease Course of Patients With Pericentral Retinitis PigmentosaAmerican Journal of Ophthalmology, 2005
- Testing for triallelism: analysis of six BBS genes in a Bardet–Biedl syndrome family cohortEuropean Journal of Human Genetics, 2005
- Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndromeNature Genetics, 2004
- Identification and characterization of rod-derived cone viability factorNature Genetics, 2004
- Long-Term Protection of Retinal Structure but Not Function Using RAAV.CNTF in Animal Models of Retinitis PigmentosaMolecular Therapy, 2001
- Usher syndrome: Definition and estimate of prevalence from two high-risk populationsJournal of Chronic Diseases, 1983